Company Filing History:
Years Active: 1976
Title: David Andrew Droppleman: Innovator in Medical Compositions
Introduction
David Andrew Droppleman is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of medical compositions, particularly in the treatment of conditions associated with inflammation and gastric bleeding.
Latest Patents
Droppleman holds a patent for "Compositions to suppress gastric bleeding in indomethacin." This patent also includes methods for treating symptomatic conditions of inflammation due to chronic and acute rheumatic and degenerative joint disease. His innovative approach combines indomethacin or phenylbutazone with a phenoxymethyl-2-oxazolidinone, resulting in a beneficial reduction in the side effects of ulceration and bleeding in the lower intestinal tract, which are typically associated with these medications.
Career Highlights
Droppleman is affiliated with A. H. Robins Company, Incorporated, where he has been able to apply his expertise in developing medical solutions. His work has contributed to advancements in pharmaceutical compositions that aim to improve patient outcomes.
Collaborations
One of his notable coworkers is Reevis S. Alphin, with whom he has likely collaborated on various projects within the company.
Conclusion
David Andrew Droppleman is a distinguished inventor whose work in medical compositions has the potential to significantly impact the treatment of inflammatory conditions. His innovative approaches continue to pave the way for advancements in the pharmaceutical industry.